Brief: Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2021 Financial Results And Provides Corporate Update

Intra-Cellular Therapies

01/03/2022 12:45

March 1 (Reuters) - Intra-Cellular Therapies Inc  ITCI.O :
    * INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND
FULL-YEAR
2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * Q4 REVENUE ROSE 106 PERCENT TO $25.7 MILLION
    * QTRLY LOSS PER SHARE $1.05

Source text for Eikon:  ID:nGNX5JSQJF 
Further company coverage:  ITCI.O 

 ((Reuters.Briefs@thomsonreuters.com;))